Bone Therapeutics

company

About

Bone Therapeutics is a biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.

  • 101 - 250

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
€16M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2006
Number Of Employee
101 - 250
Operating Status
Active

Bone Therapeutics is a international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's unique
knowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products,
tailored in-house production methods, and minimally invasive treatment techniques.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€23.70M
Bone Therapeutics has raised a total of €23.70M in funding over 2 rounds. Their latest funding was raised on Jul 1, 2021 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 1, 2021 Post-IPO Debt €16M 1 European Investment Bank Detail
Jan 28, 2013 Series D €7.70M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Bone Therapeutics is funded by 2 investors. European Investment Bank and Nausicaa Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Post-IPO Debt
Nausicaa Ventures Series D